Two years ago, the member states of the European Union announced that the EMA was moving to the Netherlands – to Zuidas to be exact. Construction work on the building was completed in the space of 18 months – an unprecedented speed. Construction officially started at the end of May last year. Less than four months later, the building had already reached its highest point.
This sterling effort was needed to prevent disruption to the EMA’s important work as far as possible. The EMA is responsible for the quality and safety of new human and animal medicines authorised for use on the European market. Minister Bruno Bruins (Medical Care and Sport) said: ‘the fact that the EMA will soon be able to move into the new headquarters on schedule is a wonderful and important result. In the interests of patients in Europe, it is vital that the EMA can continue its important work with as little disruption as possible.’ Bruins spoke of his pride about the collaboration between the various ministries, the City of Amsterdam, the EMA construction consortium (Dura Vermeer/Heijmans) and the EMA.